We were incorporated in Malaysia under the Companies Act 1965 on 27 July 2016 as a private limited company under the name of Nova Wellness Group Sdn Bhd. The Company is also deemed registered under the Act as at 31 January 2017. We subsequently converted to a public limited company on 31 October 2017 to facilitate our Listing.
Our principal activity is in investment holding while our subsidiary, Nova Laboratories is principally involved in the development, production and sales of nutraceutical and skincare products; and OEM development and production of nutraceutical products.
Board of Directors
Dr Abdul Manaf Bin Mohamad Radzi was appointed to the Board on 10 October 2017 as an Independent Non-Executive Chairman.
He holds a Doctor of Philosophy in Physical Chemistry and minor in Inorganic Chemistry from University of Tennessee, Knoxville, United States of America.
Dr Abdul Manaf Bin Mohamad Radzi started his career in 1977 as a researcher at the chemistry laboratory in Northern Illinois University. In 1988 he joined ICI Fertilizers Sdn Bhd as a Technical Executive and was promoted to Marketing Executive in 1990. In 1992, he joined PETRONAS Petroleum Research Institute (now known as PETRONAS Research & Scientific Services Sdn Bhd) as an Agrochemical Executive. In 1994, he was transferred to the Malaysian International Trading Corporation Sdn Bhd (a subsidiary of PETRONAS Research Sdn Bhd) as a trader for urea and agrochemicals in Vietnam.
In 1995, he joined FRC Manufacturing (M) Sdn Bhd as a Technical Executive. In 1996, he joined ACP Industries Berhad as the Manager for special projects division. In 2004 he joined the education sector and became a lecturer in Sunway College. In 2005, he joined Chemical Company of Malaysia Berhad as the Group Market Development Manager and was promoted to Senior Manager in 2006. In 2007, he was promoted as the General Manager of CCM Duopharma Biotech Berhad (a subsidiary of Chemical Company of Malaysia Berhad).
In 2009, he joined Innovax Sdn Bhd as the Chief Scientific Officer. In 2010, he joined Malaysian Bioeconomy Development as the Senior VicePresident of its Industrial Division. In 2015, he served as the Senior VicePresident of the University-Industry Partnership Division in Malaysian Bioeconomy Development. He also served as a member of the Scientific Advisory Board of Bioalpha Holdings Berhad before retiring in 2017.
Phang Nyie Lin was appointed to the Board on 10 October 2017 as the Group Managing Director.
He holds a Bachelor of Pharmacy from Science University of Malaysia. He started his career as a pharmacist trainee in the pharmacy department of Ipoh General Hospital, Perak (now known as Hospital Raja Permaisuri Bainun). He became a registered pharmacist with the Ministry of Health after he completed his training in 1981. In 1983, he was transferred to the National Tuberculosis Centre (now known as the Department of Respiratory Medicine, Hospital Kuala Lumpur) to serve as a pharmacist. In 1985, he left the National Tuberculosis Centre to set up Farmasi Sepadu, a community pharmacy in Sungai Pelek, Selangor, which was involved in the distribution of animal health products to livestock farms. In 1989, he established Nova Laboratories Sdn Bhd.
As the Group Managing Director, he is responsible for providing the strategic direction and overseeing the overall business operations of our Group. He also holds the position of Chief Research Officer and is responsible for overseeing all R&D activities including conceptualising ideas for new product developments and re-formulation of existing products.
Phang Yeen Nung was appointed to the Board on 10 October 2017 as an Executive Director.
He holds a Bachelor of Laws from University of Kent, United Kingdom. He started his career as a Marketing Executive in Nova Laboratories.
In 2014, he was promoted to Business Development Director and in that capacity was responsible for identifying new business opportunities.
Phang Yeen Aun was appointed to the Board on 10 October 2017 as an Executive Director.
He holds a Bachelor of Pharmacy from International Medical University, Malaysia. He started his career as a pharmacist trainee in the pharmacy department of Hospital Tuanku Ja’afar, Seremban. In 2011, he joined Nova Laboratories as a Marketing Executive and in that capacity was responsible for developing and executing new marketing plans and promotion campaigns for our products and the “NOVA” brand in the industry.
In 2012, he served as the Managing Director of Nutraphyll where he was responsible for providing the strategic direction and overseeing the overall business operations. Nutraphyll owned and operated six retail outlets exclusively selling our House Brand products. Nutraphyll was previously controlled by our Promoters through their shareholdings and directorships in Nutraphyll until August 2017.
In 2017, he left Nutraphyll and joined our Group as the Executive Director
Sulaiman Bin Haji Ahmad was appointed to the Board on 10 October 2017 as the Non Independent Non-Executive Director.
He holds a Bachelor of Pharmacy from the Science University of Malaysia. He became a registered pharmacist with the Ministry of Health after he completed his training in 1982. He started his career as a pharmacist in the manufacturing unit of the Sabah Central Medical Store and Hospital Queen Elizabeth, Sabah in 1982. In 1985, he was transferred to the National Pharmaceutical Control Bureau (now known as National Pharmaceutical Regulatory Agency) as an Analytical Pharmacist responsible for product analysis.
In 1990, he was promoted to Senior Pharmacist and was subsequently transferred to the GMP division of the National Pharmaceutical Control Bureau as a GMP Auditor responsible for conducting GMP audits. In 2005, he was promoted to Head of Department of Compliance and Licensing for the GMP division until 2008.
In 2008, he was transferred to Hospital Klang, Selangor as Chief Pharmacist and the Head of its pharmacy department. In 2009, he was transferred to Hospital Raja Permaisuri Bainun, Perak as Chief Pharmacist and the Head of its pharmacy department. In 2010, he was promoted and transferred back to National Pharmaceutical Control Bureau as Deputy Director to lead its GMP and licensing division. He retired from his role as Deputy Director in 2016.
Sim Seng Loong @ Tai Seng was appointed to the Board on 10 October 2017 as an Independent NonExecutive Director. He is the Chairman of the Audit Committee and Risk Management Committee, and a member of the Remuneration and Nomination Committees.
He is a chartered accountant and has been a member of Malaysian Institute of Certified Public Accountants (“MICPA”) (previously known as Malaysian Association of Certified Public Accountants) since May 1994, Malaysian Institute of Accountants since March 1995 and Certified Practising Accountant Australia since March 2008.
He started his career as an Auditor with a big four accounting firm from 1988 until 2004. In 2004, he admitted as a Partner of an accounting firm, R.K. & Associates. In 2007, he joined Eaton Industries Pty. Ltd. (Australia) as a Corporate Accountant where he was tasked to coordinate the company’s world-wide restructuring exercise. He was transferred to Shanghai Eaton Engine Components Ltd, China in 2009 as a Financial Controller. He joined The BIG Group Sdn Bhd in January 2012 as Chief Financial Officer and Chief Operating Officer before leaving in 2013. During his time at The BIG Group Sdn Bhd, he was primarily responsible for the finance and information technology functions of the company and day-to-day operations which also includes new restaurant openings. In 2013, he was appointed as the Chief Financial Officer of Petrol One Resources Berhad. In 2019, he left Petrol One Resources Berhad and joined Silverpack Sdn Bhd as the Chief Financial Officer, a position he assumes to present.
Over the years, he has accumulated extensive experience not only in supervising financial audit and reporting accountant projects for corporate exercises like mergers, acquisitions and IPO, he also oversees overall finance function and daily business operations as well as leading and coordinating worldwide restructuring exercise as Chief Financial Officer.
Directorship in other public companies and listed issuers:
- Pentamaster International Limited (Independent Non-Executive Director)
- Ramssol Group Berhad (Independent Non-Executive Director)
Tan Mio Har was appointed to the Board on 10 October 2017 as an Independent Non-Executive Director.
She holds a Diploma in Business Studies in Accounting from Tunku Abdul Rahman College, Malaysia. She has been a member of the Association of Chartered Certified Accountants since 2011 and she was admitted as a fellow of Association of Chartered Certified Accountants in May 2016. She has also been a member of the Malaysian Institute of Accountants since 2016.
She started her career as an Auditor with Adrian Yeo & Co in 2007 where she performed auditing work on companies in various industries. In 2009, she left the company to join Palm Gold Corporation Sdn Bhd as an Internal Audit Executive where she performed risk-based internal audits and reviewed the suitability and compliance of the company’s internal control policies and procedures.
In 2012, she left Palm Gold Corporation Sdn Bhd and joined ST Rock Blasting Sdn Bhd as an Accountant where her responsibilities include handling financial accounts and taxation matters as well as preparing analytical reviews of the company’s finance operations, a position she still holds.